There’s multiple reasons why employers are shedding existing relationships with the jumbo Pharmacy Benefit Managers (PBMs) in favor of alternative PBM models. Lori Daugherty, CEO of RxLogic, published a thought-provoking article in BenefitsPRO that highlighted these motivations:
Why Traditional PBMs are Problematic
Daugherty explains, “Behemoth PBMs camouflage pricing with hidden fees, implement rebate-driven policies and utilize outdated data reporting systems that introduce inefficiencies that actually increase expenses, limit transparency and restrict flexibility. Their opaque practices, rigid structures and excessive utilization of intermediaries make it difficult for plan sponsors to determine how much they truly pay for medications.”
She cites industry forecasts that over the next 5–10 years, PBMs will evolve into fully integrated, technology-enabled platforms that provide real-time visibility into all aspects of the pharmacy ecosystem.
Limitations of Traditional PBMs
Technology is the Key to Making the Transition
Upending longstanding relationships with large PBMs requires the support of smart technology and innovative solutions. But few – if any -- alternative PBM models have the internal resources or capabilities to deliver on this promise. To provide these competencies, they are partnering with RxLogic, an industry leader with a track record to deliver:
Future-Forward PBMs Embrace Technology, Transparency and Integration
As alternative PBMs displace traditional, obsolete models, they will increasingly rely upon technology-driven advancements that provide access to actionable data, true cost visibility and customizable models that optimize pharmacy benefits. As a result, these new-age PBMs can more effectively compete for market share and bring greater value to clients seeking cost predictability and improved patient outcomes.
Daugherty projects that interoperability will become a standard expectation throughout the industry: “PBMs will cease to perform as opaque middlemen as they transition to a more valuable role as transparent, patient-first facilitators that connect all stakeholders in the pharmaceutical supply chain. The regulatory environment is changing as the industry shift is already underway, ushering in a new era for controlled costs, enhanced efficiency and improved pharmacy benefit management. Our entire RxLogic team is proud to be a leading player in this future.”
Read the full article here.